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Abstract
Major research trials have provided insight into the scope of type 2 diabetes in youth. The 
National Diabetes Education Program offers resources to help school nurses support children with 
or at risk for type 2 diabetes.
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Once considered a disease of older adults, type 2 diabetes now occurs among youth. This 
has significant public health consequences, as these youth are likely to develop 
complications of diabetes, including retinopathy, nephropathy, neuropathy, and 
cardiovascular disease, at a time that should be the most active and productive of their lives. 
They will need significant support from their families, medical team, and school community 
to successfully manage their disease.
To understand the scope of the problem and provide population-based statistics for diabetes 
in U.S. youth, the SEARCH for Diabetes in Youth study was started in 2000 by the Centers 
for Disease Control, with co-funding from the National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK). In 2001, there were approximately 154,000 youth under the 
age of 20 years with diabetes (SEARCH for Diabetes in Youth Study Group et al., 2006). In 
2002–2003, approximately 15,000 youth were being newly diagnosed annually with type 1 
diabetes and 3,700 with type 2 diabetes (Writing Group for the SEARCH for Diabetes in 
Youth Study Group et al., 2007).
In non-Hispanic white youth ages 10 to 19 years, 15% of new cases of diabetes are type 2. 
However, type 2 diabetes predominates in minority youth (86% of new cases among 
American Indians, 70% among Asian/Pacific Islanders, 58% among Blacks, and 46% 
among Hispanics). Type 2 diabetes is rarely seen in children younger than 10 years of age, 
even in minority populations. Nurses in schools with large minority populations should be 
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aware of the increased risk of type 2 diabetes in their student population. Since 2002, 
SEARCH has been ascertaining new cases of diabetes annually and will soon provide 
updated data to address whether type 2 diabetes is increasing. SEARCH has also described 
in detail the characteristics of youth with type 2 diabetes. Perhaps of greatest concern is that 
27% of the youth with type 2 diabetes enrolled in SEARCH had poor glycemic control (A1C 
> 9.5%), with the highest rates among youth from racial/ethnic minority groups (Petitti et 
al., 2009).
The level of poor glycemic control in youth with type 2 diabetes highlights the need for 
prevention of type 2 diabetes and of obesity, which puts people at risk for developing type 2 
diabetes. Schools have an opportunity to reduce diabetes risk because of the large amount of 
contact time they have with youth.
In 2006, the NIDDK, with support from the American Diabetes Association, sponsored the 
HEALTHY study to evaluate a randomized, 3-year, school-based program to decrease risk 
factors for type 2 diabetes. The HEALTHY intervention provided healthier choices from the 
cafeteria and vending machines (e.g., lower fat foods, more fruits and vegetables, and drinks 
with no added sugar), longer and more intense periods of physical activity in physical 
education classes, and activities and awareness campaigns that promote long-term healthy 
behaviors. Forty-two middle schools were randomized; half received the intervention and 
half served as comparison schools. Over 70% of the 4,603 students in the HEALTHY cohort 
were eligible for free or reduced-price meals and were either Black or Hispanic. Half of the 
cohort was either overweight or obese at the beginning of the study in 6th grade, based on 
body mass index. The primary outcome was the combined rate of overweight and obesity 
(HEALTHY Study Group et al., 2010). The combined number of overweight and obese 
students declined by 4% in both the intervention and comparison schools. However, the 
prevalence of obesity declined significantly more in the intervention schools among students 
who were overweight or obese at the onset of the study. Decreasing the number of obese 
children could have significant effects in the population risk of diabetes, since obese 
children have the highest risk of developing type 2 diabetes.
While prevention remains a priority, optimal treatment for youth with type 2 diabetes must 
be provided. Currently, metformin is the only oral agent approved by the Food and Drug 
Administration for use in children. Treatment paradigms must be developed with 
consideration given to the physiological and psychological changes that occur during 
adolescence. To test the value of early aggressive therapy, NIDDK funded the TODAY 
(Treatment Options for type 2 Diabetes in Adolescents and Youth) Study (TODAY Study 
Group et al., 2012), which randomized 699 youth ages 10 to 17 with less than 2 years of 
diabetes to metformin monotherapy, metformin plus rosiglitazone, or metformin plus an 
intensive lifestyle program. The TODAY cohort was predominately minority (32% African 
American, 41% Hispanic, 6% American Indian) and of low socio-economic status (42% 
with household income <$25,000), reflecting the increased risk of type 2 diabetes in these 
groups. The primary outcome was the time to treatment failure, defined as an A1C > 8.0% 
for 6 months. Half of the metformin group was unable to maintain glycemic control. The 
failure rate of metformin monotherapy was much higher than anticipated based on published 
information in adults with type 2 diabetes. The addition of rosiglitazone decreased the 
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failure rate by 25% (51.7% in the metformin group versus 38.6% in the metformin and 
rosiglitazone group). The metformin plus lifestyle group was intermediate (46.6%) but not 
statistically different from the metformin alone group. Of note, African American youth had 
a failure rate of 66% on metformin monotherapy, highlighting the need to individualize 
therapy. Further analyses are currently being conducted to understand the reason for racial/
ethnic differences in response to treatment. The level of comorbidities in TODAY 
participants is also concerning. By the end of the study, 33.8% had hypertension, 28% had 
high triglycerides, and 16.6% had microalbuminuria, underscoring the need for better 
treatment approaches.
The SEARCH study continues to illuminate the problem of type 2 diabetes in children. 
HEALTHY and TODAY were major trials that inform health professionals about prevention 
and treatment of type 2 diabetes in children. To further enhance understanding of diabetes in 
youth and treatment strategies, the National Diabetes Education Program (NDEP) provides a 
resource for school personnel entitled
Helping the Student with Diabetes Succeed: A Guide for School Personnel
School nurses can lead efforts to influence youth behaviors and prevent or manage obesity 
and type 2 diabetes. The NDEP can provide support with multiple tools and resources at 
http://www.yourdiabetesinfo.org. For example, Tips for Teens is a series of publications 
with action-oriented messages designed for multi-cultural youth to increase their physical 
activity levels, eat a healthier diet, and manage their weight.
The NDEP also offers Diabetes HealthSense, which connects nurses to both online and 
written resources for assisting students and families with changing behaviors to improve 
diabetes management. One such tool is BAM! Body and Mind, an interactive website 
designed for 9- to 13-year-olds featuring games and activities to encourage children to make 
healthier lifestyle choices. In addition, all HEALTHY materials are available for free at 
http://www.healthystudy.org. School nurses may find it helpful to become acquainted with 
these resources as they contribute to the development of healthy lifestyles in youth.
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